background
โรงพยาบาลจุฬาลงกรณ์
นัดหมายพบแพทย์
ศ.นพ.ชวลิต เลิศบุษยานุกูล

การศึกษา

- มัธยมปลาย : อัสสัมชัญ ธนบุรี

- พ.บ. : จุฬาลงกรณ์มหาวิทยาลัย พ.ศ. 2539

อื่นๆ :
»  ประกาศนียบัตรบัณฑิตทางวิทยาศาสตร์การแพทย์คลินิกสาขารังสีวิทยา พ.ศ. 2543
»  วุฒิบัตรแสดงความรู้ความชำนาญในการประกอบวิชาชีพเวชกรรม สาขารังสีรักษา พ.ศ.2545
»  อนุมัติบัตรแสดงความรู้ความชำนาญในการประกอบวิชาชีพเวชกรรม สาขาเวชศาสตร์ครอบครัว พ.ศ.2546

- บรรจุเป็นนายแพทย์ 5 สาขา รังสีรักษา ฝ่ายรังสีวิทยา รพ.จุฬาลงกรณ์ สภากาชาดไทย ตั้งแต่ปี พ.ศ. 2545

- 2549 ผู้ช่วยศาสตราจารย์ สาขารังสีรักษาและมะเร็งวิทยา ภาควิชารังสีวิทยา คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

- 2554 รองศาสตราจารย์ สาขารังสีรักษาและมะเร็งวิทยา ภาควิชารังสีวิทยา คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

- 2561 ศาสตราจารย์ สาขารังสีรักษาและมะเร็งวิทยา ภาควิชารังสีวิทยา คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

CERTIFICATE

1996 : Doctor of Medicine, Chulalongkorn University

2000 : Graduate Diploma in Clinical Sciences (Radiology), Chulalongkorn University

2002 : Diplomat, Thai Board of Radiation Oncology

2003 : Diplomat,Thai Board of Family Medicine

2004 : Visiting fellow in intensity-modulated radiation therapy (IMRT), University of Pittsburgh Medical Center, Pennsylvania, USA

MEDICAL LICENSER

Unrestricted Medical Licenser No. 21187 (The Medical Council of Thailand)

ACADEMIC EXPERIENCE

2002-2006 : Instructor: Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn Hospital

2006-2011 : Assistant Professor: Division of Radiation Oncology, Department of Radiology

2011-2018 : Associate Professor: Division of Radiation Oncology, Department of Radiology

2018-present : Professor: Division of Radiation Oncology, Department of Radiology

ADMINISTRATION

2554-2561 : ดำรงตำแหน่ง ผู้ช่วยผู้อำนวยการโรงพยาบาลจุฬาลงกรณ์ ด้านสนับสนุนบริการ

2555-ปัจจุบัน : บรรณาธิการ วารสารสมาคมรังสีรักษาและมะเร็งวิทยาแห่งประเทศไทย

2560-2563 : ประธานหลักสูตร ปริญญาตรีสาขารังสีเทคนิค หลักสูตรร่วมคณะแพทยศาสตร์และคณะสหเวชศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

2563-2566 : หัวหน้าสาขารังสีรักษาและมะเร็งวิทยา ภาควิชารังสีวิทยา คณะแพทยศาสตร์ จุฬาลงกรณ์มหาวิทยาลัย

BOOKS

  • มะเร็งคอหอยหลังโพรงจมูก (Nasopharyngeal Cancer: A Multidisciplinary Approach) ISBN: 978-616-445-885-7 
  • รังสีรักษาร่วมสมัย ISBN: 978-616-728740-9
  • รู้จัก รู้เรื่อง รู้รักษา โรคมะเร็ง ISBN: 978-616-782-962-3 
  • รู้จัก รู้เรื่อง รู้รักษา โรคมะเร็ง เป็นมะเร็ง(หรือไม่เป็น) ก็ต้องอ่าน ISBN: 978-616-7287-34-8
  • มะเร็งเต้านม ISBN: 978-616-529-040-1
  • 100 เรื่อง รู้จัก รู้รักษามะเร็งเต้านม ISBN: 978-616-821-236-3
  • 100 เรื่อง รู้จัก รู้รักษา โรคมะเร็ง หู คอ จมูก, ชวลิต เลิศบุษยานุกูล, สาริน กิจพาณิชย์  ISBN : 978-616-8212-46-2
  • 100 เรื่อง รู้จัก รู้รักษา โรคมะเร็ง ปอด, ชนม์นิภา นันทวิทยา,  ชวลิต เลิศบุษยานุกูล ISBN 978-616-8212-56-1

PUBLICATIONS/ABSTRACTS

Khongwirotphan S, Oonsiri S, Kitpanit S, Prayongrat A, Kannarunimit D, Chakkabat C, Lertbutsayanukul C, Sriswasdi S, Rakvongthai Y. Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma. PLoS ONE 2024; 19: e0298111.

Wongwattananard S, Prayongrat A, Srimaneekarn N, Hayter A, Sophonphan J, Kiatsupaibul S, Veerabulyarith P, Rakvongthai Y, Ritlumlert N, Kitpanit S, Kannarunimit D, Lertbutsayanukul C, Chakkabat C. A multivariable normal tissue complication probability model for predicting radiation-induced hypothyroidism in nasopharyngeal carcinoma patients in the modern radiotherapy era. Journal of Radiation Research 2024; 65: 119-126.

Prayongrat A, Noppaving P, Chobarporn T, Sudhinaraset N, Teeyapun N, Pakvisal N, Jantarabenjakul W, Sophonphan J, Lertbutsayanukul C, Poovorawan Y. Safety and Immunogenicity of Homologous and Heterologous Adenoviral-Vectored and mRNA COVID-19 Vaccine Regimens in Radiotherapy Patients. Vaccines 2023; 11: 1135.

Leelayuwatanakul N, Thanthitaweewat V, Wongsrichanalai V, Lertbutsayanukul C, Prayongrat A, Kitpanit S, Sriprasart T. The prognostic predictors of airway stenting in malignant  airway involvement from esophageal carcinoma. Journal of Bronchology and Interventional Pulmonology 2023; 30: 277-284.

Piboonratanakit P, Ferreira JN, Pravinvongvuthi K, Maison K, Urkasemsin G, Boonroung T, Prayongrat A, Lertbutsayanukul C, Sucharitakul J, Vacharaksa A. Trehalose versus carboxymethylcellulose oral spray for relieving radiation-induced xerostomia in head and neck cancer patients: a randomized controlled trial. BMC Oral Health 2023; 23: 288.

Ritlumlert N, Wongwattananard S, Prayongrat A, Kitpanit S, Kannarunimit D, Chakkabat C, Lertbutsayanukul C, Sriswasdi S, Rakvongthai Y. Using CT image-based biomarkers to improve the prediction of hypothyroidism after nasopharyngeal radiotherapy: a preliminary result. ACM International Conference Proceeding Series 2023: 270-273.

Ritlumlert N, Wongwattananard S, Prayongrat A, Oonsiri S, Kitpanit S, Kannarunimit D, Chakkabat C, Lertbutsayanukul C, Sriswasdi S, Rakvongthai Y. Improved prediction of radiation-induced hypothyroidism in nasopharyngeal carcinoma using pre-treatment CT radiomics. Scientific Reports 2023; 13: 17437.

Prayongrat A, Kitpanit S, Lertbutsayanukul C, Saikaew P, Boonrueng T, Mekayarajjananonth T, Vacharaksa A. Digital fabrication of customized intraoral appliances for head and neck radiotherapy  Heliyon 2023; 9: e15374

Kannarunimit D, Chotirut A, Prayongrat A, Pakvisal N, Sitthideatphaiboon P, Lertbutsayanukul C, Kitpanit S, Chakkabat C, Vinayanuwattikun C. A prospective randomized study comparing the efficacy between povidone-iodine gargling and benzydamine hydrochloride for mucositis prevention in head and neck cancer patients receiving concurrent chemoradiotherapy (2023) Heliyon 2023; 9:e15437

Lertbutsayanukul C, Kitpanit S, Kannarunimit D, Chakkabat C, Oonsiri S, Thephamongkhol K, Puataweepong P, Katanyoo K, Sukhaboon J, Tovanabut C, Chongsathientham S, Treeratsapanich P, Soonthornrak J, Prayongrat A. High-dose Intensity-modulated proton therapy versus Standard-dose Intensity-modulated RadIation therapy for esophageal squamous cell carcinoma (HI-SIRI): study protocol for a randomized controlled clinical trial  Trials 2022, 23: 897

Tangyoosuk T, Lertbutsayanukul C, Jittapiromsak N. Utility of diffusion-weighted magnetic resonance imaging in predicting the treatment response of nasopharyngeal carcinoma Neuroradiology Journal 2022; 35 :477-485.

Oonsiri S, Kitpanit  S, Kannarunimit D ,  Chakkabat C,  Lertbutsayanukul C, Prayongrat A. Comparison of intensity modulated proton therapy beam configurations for treating thoracic esophageal cancer. Phys Imaging Radiat Oncol 2022; 22:51-56.

Paprad  T, Lertbutsayanukul C, Jittapiromsak  N. Value of Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Prediction of Treatment Outcomes in Nasopharyngeal Carcinoma. J Comput Assist Tomogr. 2022; 46:664-672.
Oonsiri P, Nantavithya C, Lertbutsayanukul C , Sarsitthithum T, Vimolnoch M, Tawonwong T, Saksornchai K. Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy. Radiat Oncol 2022;17:20
Lertbutsayanukul C, Pitak M, Nantavithya C. Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer. Radiat Oncol J 2022; 40: 141-150.
Tangyoosuk T , Lertbutsayanukul  C, Jittapiromsak N. Utility of diffusion-weighted magnetic resonance imaging in predicting the treatment response of nasopharyngeal carcinoma Neuroradiol J. 2021;19714009211055191. doi: 10.1177/19714009211055191.
Jaruthien T, Kitpanit S, Kannarunimit D, antavithya C, Prayongrat A, Alisanant P, Saksornchai K, Amornwichet N, Raiyava T, Chakkabat C, Lertbutsayanukul C, Khorprasert C, Shotelersuk K. Flattening filter free stereotactic body radiation therapy for lung tumors: outcomes and predictive factors. Translational Cancer Research 2021;10:571-580
Chow JCH, Lee A, Bao KKH, Cheung KM, Chan JCH, Tam AHP, Sung WWY,  Tsui TYM, Chuk EYH, Chung DHS, Wong KH, Prayongrat A, Lertbutsayanukul C,  Kannarunimit D, Chakkabat C, Kitpanit S. Cranial neuropathies in advanced nasopharyngeal carcinoma: Neurological recovery after modern radiotherapy and systemic chemotherapy.  Radiother Oncol. 2021;163:221-228. doi: 10.1016/j.radonc.2021.08.022.
Value of dynamic contrast-enhanced magnetic resonance imaging for determining the plasma Epstein-Barr virus status and staging of nasopharyngeal carcinoma.Sriyook A, Lertbutsayanukul C, Jittapiromsak N. Clin Imaging. 2020 Nov 4;72:1-7.
Hypothyroidism after radiotherapy for nasopharyngeal carcinoma. Anussara Prayongrat, Chawalit Lertbutsayanukul. Ann Nasopharynx Cancer 2020;4:3 | http://dx.doi.org/10.21037/anpc.2020.03.03
Long-term patient-rated cosmetic and satisfactory outcomes of early breast cancer treated with conventional versus hypofractionated breast irradiation with simultaneous integrated boost technique. Lertbutsayanukul C, Pitak M, Ajchariyasongkram N, Rakkiet N, Seuree F, Prayongrat A. Breast J. 2020 Jul 9. doi: 10.1111/tbj.13960.
Validation of the Scored Patient-Generated Subjective Global Assessment (PG-SGA) in Thai Setting and Association with Nutritional Parameters in Cancer Patients. Nitichai N, Angkatavanich J, Somlaw N, Voravud N, Lertbutsayanukul C.Asian Pac J Cancer Prev. 2019;20:1249-1255. doi: 10.31557/APJCP.2019.20.4.1249.
Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial. Kitpanit S, Jittapiromsak N, Sriyook A, Prayongrat A, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Jpn J Clin Oncol. 2019 doi: 10.1093/jjco/hyz109. 
A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma. Chawalit Lertbutsayanukul, Anussara Prayongrat, Danita Kannarunimit, Chakkapong Chakkabat, Buntipa Netsawang and Sarin Kitpanit. Strahlentherapie und Onkologie, 2018;194:375-385.
High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma. Chawalit Lertbutsayanukul,Chadin Tharavej, Naruemon Klaikeaw, Anussara Prayongrat, Chutinan Lowanitchai, and Virote Sriuranpong. Thorac Cancer. 2017 May; 8(3): 219–228.
Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma. Anussara Prayongrat, Chakkapong Chakkabat, Danita Kannarunimit, Pokrath Hansasuta, Chawalit Lertbutsayanukul. J Radiat Res. 2017 Jul; 58(4): 509–516.
Prognostic Value of Plasma EBV DNA for Nasopharyngeal Cancer Patients during Treatment with Intensity-modulated Radiation Therapy and Concurrent Chemotherapy. Chawalit Lertbutsayanukul, Danita Kannarunimit, Anussara Prayongrat, Chakkapong Chakkabat, Sarin Kitpanit, Pokrath Hansasuta. Radiol Oncol. 2018 Jun; 52(2): 195–203.
Validation of previously reported predictors for radiation-induced hypothyroidism in nasopharyngeal cancer patients treated with intensity-modulated radiation therapy, a post hoc analysis from a Phase III randomized trial. Chawalit Lertbutsayanukul, Sarin Kitpanit, Anussara Prayongrat, Danita Kannarunimit, Buntipa Netsawang, Chakkapong Chakkabat. J Radiat Res. 2018 Jul; 59(4): 446–455.
A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events. Songthong AP, Kannarunimit D, Chakkabat C, Lertbutsayanukul C. Radiat Oncol. 2015;10:166
Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma. Songthong A, Chakkabat C, Kannarunimit D, Lertbutsayanukul C. Radiol Oncol. 2015 Mar 25;49(2):155-62. doi: 10.2478/raon-2014-0044. eCollection 2015.
Efficacy of Intensity-Modulated Radiotherapy with Concurrent Carboplatin in Nasopharyngeal Carcinoma. Anussara Songthong,Chakkapong Chakkabat,Danita Kannarunimit,Chawalit Lertbutsayanukul.  Radiology and Oncology. ISSN (Online) 1581-3207, DOI: 10.2478/raon-2014-0044, December 2014.
Phase I study of integrating PET/CT and dose-escalated intensity modulated radiation therapy using a simultaneous integrated boost technique for thoracic esophageal cancer. Chawalit Lertbutsayanukul, Piyavisetpat N, Sriuranpong V, Chiewaratanapong P, Tharavej C, Klaikeaw N. Asian Biomedicine 2013; 7:657-667
Skin Toxicity and Cosmesis after Hypofractionated Whole Breast Irradiation for Early Breast Cancer. Kitwadee Saksornchai MD, Prayuth Rojpornpradit MD, Kanjana Shotelersak MD, Chawalit Lertbutsayanukul MD, Chakkapong Chakkabat MD, Tassapong Raiyawa MD. J Med Assoc Thai 2012; 95 (2): 229-40.

Dosimetric study of inverse-planed intensity modulated, forward-planned intensity modulated and conventional tangential techniques in breast conserving radiotherapy. Rongsriyam K, Rojpornpradit P, Lertbutsayanukul C, Sanghangthum T, Oonsiri S. J Med Assoc Thai. 2008 Oct;91(10):1571-82.

A two-year experience of implementing 3 dimensional radiation therapy and intensity-modulated radiation therapy for 925 patients in King Chulalongkorn Memorial Hospital. Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Sanghangthum T, Oonsiri S, Ayuthaya II, Jumpangern C, Suriyapee S, Rojpornpradit P. J Med Assoc Thai. 2008 Feb;91(2):215-24.

Adjuvant therapy for early-stage endometrial cancer: a review. Tangjitgamol S, Manusirivithaya S, Lertbutsayanukul C. Int J Gynecol Cancer. 2007;17: 949–956

Measurements of patient’s setup variation in intensitymodulated radiation therapy of head and neck cancer using electronic portal imaging device. Naiyanet N, Oonsiri S, Lertbutsayanukul C, Suriyapee S. Biomed Imaging Interv J 2007; 3(1):e30

Intensity-modulated radiation therapy in head-and-neck cancer, first report in Thailand. Lertbutsayanukul C, Khorprasert C, Shotelersuk K, Jumpangern C, Sanghangthum T, Oonsiri S, Ayuthaya II, Suriyapee S, Wadwongtham W, Supanakorn S, Kerekanjanarong V, Rojpornpradit P. J Med Assoc Thai. 2006 Dec;89(12):2068-76.

Preoperative capecitabine with pelvic radiotherapy for locally advanced rectal cancer (phase I trial). Veerasarn V, Phromratanapongse P, Lorvidhaya V, Lertsanguansinchai P, Lertbutsayanukul C, Panichevaluk A, Boonnuch W, Chinswangwatanakul V, Lohsiriwat D, Rojanasakul A, Thavichaigarn P, Jivapaisarnpong P. J Med Assoc Thai. 2006 Nov;89(11):1874-84.

Pattern of local-regional recurrence in patient with early breast cancer after mastectomy: an analysis of 357 cases at King Chulalongkorn Memorial Hospital. Lertsanguansinchai P, Lertbutsayanukul C, Chatamra K, Shotelersuk K, Voravud N, Khorprasert C. J Med Assoc Thai. 2004 Sep;87 Suppl 2: S168-74.

Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma. Lertsanguansinchai P, Lertbutsayanukul C, Shotelersuk K, Khorprasert C, Rojpornpradit P, Chottetanaprasith T, Srisuthep A, Suriyapee S, Jumpangern C, Tresukosol D, Charoonsantikul C. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1424-31.

Intracranial germ cell tumors: experience in King Chulalongkorn Memorial Hospital. Shotelersuk K, Rojpornpradit P, Chottetanaprasit T, Lertbutsayanukul C, Lertsanguansinchai P, Khorprasert C, Asavametha N, Suriyapee S, Jumpangern C. J Med Assoc Thai. 2003; 86:603-11.

Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital. Lertsanguansinchai P, Chottetanaprasith T, Chatamra K, Sampatanukul P, Wannakrairot P, Rojpornpradit P, Shotelersuk K, Lertbutsayanukul C, Boonjunwetwat D, Vajragupta L. J Med Assoc Thai. 2002 Jun;85 Suppl 1:S193-202.

Results of radiation therapy in stage IB cervical carcinoma at King Chulalongkorn Memorial Hospital; fifteen-year experience. Lertbutsayanukul C, Lertsanguansinchai P, Shotelersuk K, Khorprasert C, Rojpornpradith P, Asavametha N, Pataramontree J, Suriyapee S, Tresukosol D, Termrungruanglert W. J Med Assoc Thai. 2001 Jun;84 Suppl 1:S216-27

Phase III randomized trial comparing LDH and HDR in treatment of cervical carcinoma, early report. Lertbutsayanukul C, Lertsanguansinchai P, Shotelersuk K, Khorprasert C, Rojpornpradith P, Chottetanaprasith T, Srisuthep A, Tresukosol, Termrungruanglert W. Accepted for presentation at 13th Annaul meeting of The Society of radiation oncology of Thailand Jan18-20th, 2002.

Concurrent Chemoradiation for head and neck cancer. Lertbutsayanukul C, Lertsanguansinchai P. Chula Med J 2002 Jan; 46(1): 11-17.

Basic concept of radiation therapy combined with chemotherapy. Lertbutsayanukul C, Lertsanguansinchai P. Chula Med J 2003 Aug ;47(8) :501-511

Radiochemotherapy in treatment of pancreatic cancer, evidenced based. Lertbutsayanukul C. Chula Med J 2004; 48: 171-188

Radiochemotherapy in lung cancer, evidenced based. Lertbutsayanukul C, Shotelersuk K. Medical Time CME 2004 Apr; 3(59): 43-52

Dose measurement of total scalp radiation treatment using lateral photon-electron technique. Lertbutsayanukul C, Jumpangern C, Charoonsantikul C, Sanghangthum T, Suriyapee S. Asean Journal of Radiology 2005; 11(2):67-74

Survival analysis of stage I-IIIA breast cancer patients treated with mastectomy; 11-year experience in King Chulalongkorn Memorial Hospital. Lertbutsayanukul C, Lertsanguansinchai P, Shotelersuk K, Khorprasert C, Suriyapee S, Sangsubhan C, Navicharern P. Asean Journal of Radiology 2005; 11(2): 85-96

Intensity-modulated radiation therapy. Lertbutsayanukul C. Proceeding The 8th National Cancer Conference “Empowering Cancer Control for Healthy Thailand” 2005:28

Role of radiochemotherapy in treatment of soft tissue sarcoma. Lertbutsayanukul C. Chula Med J 2005; 49(10):591-614

Intensity Modulated Radiation Therapy. Lertbutsayanukul C, Rojpornpradit P. Journal of Thai Society of Therapeutic Radiology and Oncology 2005;11:13-29

Intensity modulated radiation therapy in breast cancer. Lertbutsayanukul C. Journal of Thai Society of Therapeutic Radiology and Oncology 2006;12:85-107

Neoadjuvant chemoradiation followed by surgery for treatment of esophageal cancer. Lertbutsayanukul C. Journal of Thai Society of Therapeutic Radiology and Oncology 2008; 14:61-74

IMRT of head and neck cancer. Lertbutsayanukul C. Journal of Thai Society of Therapeutic Radiology and Oncology 2008;14:75-116

Late effects and cosmetic results of simultaneous integrated boost versus sequential boost after conventional irradiation inbreast-conserving therapy; out come of 7 months follow-up. Raiyawa T, Lertbutsayanukul C, Rojpornpradit P. J Med Assoc Thai. 2009;92(3): 390-7.

Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results. Domingo E, Lorvidhaya V, de Los Reyes R, Syortin T, Kamnerdsupaphon P, Lertbutsayanukul C, et al. Oncologist. 2009;14(8):828-34.

Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Tangjitgamol S, Anderson BO, See HT, Lertbutsayanukul C, Sirisabya N, Manchana T, et at. Lancet Oncol.2009 Nov;10(11): 1119-27.